How big is the Leukapheresis Market?

The Leukapheresis Market size is expected to reach USD 69.77 billion in 2024 and grow at a CAGR of 7.15% to reach USD 98.55 billion by 2029. Read More

What is the current Leukapheresis Market size?

In 2024, the Leukapheresis Market size is expected to reach USD 69.77 billion. Read More

Who are the key players in Leukapheresis Market?

Asahi Kasei Medical Co. Ltd, Fresenius SE & Co. KGaA, Haemonetics Corporation, Macopharma and Terumo BCT Inc. are the major companies operating in the Leukapheresis Market. Read More

Which is the fastest growing region in Leukapheresis Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Leukapheresis Market?

In 2024, the North America accounts for the largest market share in Leukapheresis Market. Read More

What years does this Leukapheresis Market cover, and what was the market size in 2023?

In 2023, the Leukapheresis Market size was estimated at USD 65.11 billion. The report covers the Leukapheresis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Leukapheresis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Leukapheresis Market Share

Statistics for the 2023 & 2024 Leukapheresis market share, created by Mordor Intelligence™ Industry Reports. Leukapheresis share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Leukapheresis Industry

The leukapheresis market is consolidated and consists of a few major players. A few major players dominate the market in terms of market share. New product developments, acquisitions, and strategic alliances are some strategies adopted by industry players. Some companies currently dominating the market are Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Macopharma, Fresenius SE & Co. KGaA, HemaCare, Key Biologics LLC, AllCells, and StemExpress.